Protalix Biotherapeutics' Series B Round

Protalix Biotherapeutics raised a round of funding on March 28, 2005. Investors include Pontifax.

Protalix Biotherapeutics is a biopharmaceutical company that specializes in the manufacture of recombinant therapeutic proteins through its ProCellEx plant cell-based protein expression system. Using …

Articles about Protalix Biotherapeutics' Series B Round: